Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

11.1%

1 terminated out of 9 trials

Success Rate

83.3%

-3.3% vs benchmark

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

100%

5 of 5 completed with results

Key Signals

5 with results83% success

Data Visualizations

Phase Distribution

8Total
P 2 (5)
P 3 (3)

Trial Status

Completed5
Not Yet Recruiting1
Recruiting1
Terminated1
Withdrawn1

Trial Success Rate

83.3%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (9)

Research Network

Activity Timeline